flu Archives -

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s

Reconfiguring COVID and influenza vaccines for long-term effectiveness

https://pharmaphorum.com/r-d/reconfiguring-covid-and-influenza-vaccines-for-long-term-effectiveness/

Generic was developed with India’s Natco.

Alvogen launches Tamiflu generic in US

https://pharmaphorum.com/news/tamiflugeneric/

Company takes $80m hit.

US authorities refuse to use AZ’s nasal flu vaccine

https://pharmaphorum.com/news/us-authorities-refuse-use-azs-nasal-flu-vaccine/

flu